San Antonio Nurses in Advanced Practice
Covering The City With Care

Diabetes & Obesity: Charting Pathways to Effective Co-management in Primary Care (Enduring from 20LV223)

CE Information
1.5 contact hours (0.3 pharmacology)
Completion Time
1 hour, 30 minutes
Available Until
November 16, 2024
Posted By
Prime CE
Prime CE Prime CE
Ready to start this activity?
Login required. You will be redirected to an external website to register for and complete this activity.

Overview

Specialties
Adult
Subspecialties
Endocrinology
Clinical Topics
Diabetes

Intended Audience: Physicians, PAs, NPs, nurses, and pharmacists

Watch this recording of a live satellite symposium at the American Academy of Family Physicians' (AAFP) 2023 Family Medicine Experience for a sneak peek at new data emerging from an innovative QI initiative examining the intersection of type 2 diabetes (T2D) and obesity in the primary care setting.

Reflecting on key findings and real-world barriers, the interactive session will facilitate discussion on practical tips and tools, including a new Diabetes and Obesity Co-Management Resource, for adopting a T2D and obesity co-management approach in the primary care setting where family medicine providers are uniquely positioned to support patients in achieving their glycemic and weight loss goals.

Learning Objectives

  • Integrate weight loss as a treatment target in diabetes treatment planning for patients with T2D and obesity
  • Identify appropriate patients with T2D for treatment intensification to support achievement of glycemic control and weight loss goals and improved health outcomes
  • Apply current evidence in treatment decision-making, including timing of treatment intensification, for patients with diabetes and obesity to support prompt glycemic control and sustained weight loss for optimization of health outcomes
  • Employ validated shared decision-making techniques into clinic workflows to engage patients with T2D in effective decision-making regarding weight loss, including communication of personalized weight loss goals and methods
  • Employ evidence-based strategies and tools to support effective tracking and management of patients with T2D and obesity

Speakers

Michelle Magee
Michelle Magee MD

Professor of Medicine
Georgetown University School of Medicine and Healthcare Sciences
Director, Medstar Health Diabetes Institute
MedStar Washington Hospital Center
Washington, DC

Kathleen Reims
Kathleen Reims MD, FAAFP

Family Medicine Physician
Retired Chief Medical Officer, CSI Solutions, LLC
Lafayette, CO

I am a Board-Certified Family Medicine physician who is a Principal of CSI Solutions, LLC and its Chief Medical Officer. I currently co-direct the Centre for Collaboration, Motivation and Innovation (CCMI), a non-profit organization dedicated to building skills and confidence for better health and health care. I have served as an Improvement Advisor and Faculty for numerous health systems improvement projects and have a strong interest in patient engagement so as to respectfully include patients’ values and preferences in their care. I remain actively involved with Denver Health and Hospital’s Lowry Clinic as a volunteer preceptor serving a diverse population from around the world and hold an appointment of Assistant Clinical Professor Department of Family Medicine, School of Medicine, University of Colorado Health Sciences Center. I was privileged to be a National Health Service Corps Scholar, have over 25 years of clinical experience with underserved populations and have served as Medical Director for two Federally Qualified Health Centers. My undergraduate medical training was at Baylor College of Medicine and my Family Medicine residency was at Roanoke Memorial Hospitals. I am a member of the Motivational Interviewing Network of Trainers (MINT).

CE Information

This activity offers 1.5 contact hours (0.3 pharmacology) to attendees.

PRIME Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This activity is approved for 1.5 contact hours (which includes 0.3 hour of pharmacology).

Disclosures

*PRIME® has identified, reviewed, and mitigated all relevant financial relationships that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity.

The following individuals have identified relevant financial relationships with ineligible companies to disclose:

  • Michelle F. Magee, MD (Course Director, Speaker)
    Grants / Research Support  Medtronic, Uluru
    Speakers Bureau or other Promotional Education  ADA, ADCES, PRIMED
    The relationships reported above are related to the following therapeutic area: Endocrinology and Metabolism

The following individuals have no relevant financial relationships with ineligible companies to disclose:

  • Kathleen G. Reims, MD, FAAFP (Speaker)
  • Ryan J Atkinson, PharmD, MBA (Moderator)
  • Stephanie Joyce, PA, MSPAS, MS, RD CNSC (Reviewer)
  • Donna M Chiefari, BSc (Pharm), PharmD, RPh, FASHP (Planner)
  • Lisa Wakefield, MSN, APRN, FNP-BC (Planner)
  • Jason Welch, MD (Planner)

All PRIME® staff participating in planning and content development have no relevant financial relationships with ineligible companies to disclose.


Ready to start this activity?

Login required. You will be redirected to an external website to register for and complete this activity.

Log in and start activity